Physician profile
Michael T Adler
NPI 1639408933
$3,536.74
in general payments reported to CMS, 2019-2025
36 companies · $546 in 2025
The $546 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $347 · 2021: $540 · 2022: $373 · 2023: $655 · 2024: $654 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $537.70 | 2019-2024 | Lo Loestrin Fe |
| Evofem Biosciences, INC. | $381.31 | 2021-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $295.69 | 2019-2024 | |
| Biogen, INC. | $261.70 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $220.40 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $200.28 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $179.33 | 2023-2025 | Myfembree |
| Medtronic, INC. | $145.34 | 2023-2024 | V-Loc 180, Situate, Interstim |
| Hologic Sales and Service, LLC | $126.79 | 2020-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Exeltis, USA INC. | $126.45 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $122.55 | 2020-2021 | |
| Baxter Healthcare | $94.81 | 2024-2025 | Perclot, Floseal |
| Avion Pharmaceuticals | $85.81 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $78.42 | 2019-2022 | |
| Abbott Laboratories | $65.97 | 2021-2024 | Proclaim |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $62.56 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Allergan, INC. | $55.50 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $54.04 | 2019-2020 | |
| Millicent US INC | $53.48 | 2023-2025 | Femring, Intrarosa |
| Coopersurgical, INC. | $47.00 | 2020-2024 | Paragard T 380a |
| Amgen INC. | $38.48 | 2019-2020 | |
| Organon LLC | $30.70 | 2024-2025 | Nexplanon |
| Janssen Biotech, INC. | $25.58 | 2025 | Tremfya |
| Renovia INC | $25.30 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $23.45 | 2019 | |
| Myovant Sciences INC. | $23.10 | 2021 | |
| Smith+Nephew, INC. | $23.01 | 2019 | |
| Ethicon US, LLC | $20.33 | 2025 | Dermabond, Vistaseal, Ethicon |
| Mylan Pharmaceuticals INC. | $20.12 | 2022 | |
| Astellas Pharma US INC | $19.64 | 2024 | Veozah |
| Mission Pharmacal Company | $17.82 | 2023 | Citranatal |
| Ascend Therapeutics US, LLC | $17.34 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.72 | 2019 | |
| Exact Sciences Corporation | $14.21 | 2023 | Cologuard Collection Kit |
| Medicem INC. | $14.01 | 2020 | |
| Covidien LP | $13.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.